Manufacturing Medical Relationship Utilities 
FDA Law
MAY 27, 2024
HPM) proudly announces the return of Jennifer Newberger as a Director, further boosting its already robust medical device practice. She also specializes in medical device software and digital health. With her return to the firm, she can now utilize her recent in-house experience to help HPM’s diverse client base solve complex problems.
FDA Law
OCTOBER 14, 2021
As a scientific/medical matter, there are many variables beside the RAS device that are responsible for clinical outcomes. Given these onerous requirements, it is not a surprise that RAS device manufacturers have not sought clearance for RAS devices for oncology procedures. But these devices are not independent cancer therapeutics.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Physician's Practice
JUNE 9, 2025
a health care attorney with Roetzel & Andress, joins the show to explore the legal risks of prescribing GLP-1 medications. Financial Relationships with Pharmaceutical Companies (00:20:10)** Legal and ethical concerns for physicians with financial ties to GLP-1 drug manufacturers, including anti-kickback laws. Adler, J.D.,
GeriPal
MAY 5, 2022
Association of Sensory and Cognitive Impairment With Healthcare Utilization and Cost in Older Adults. Including more hospital utilization or healthcare utilization, maybe cognitive impairment issues. My own work focuses on hospitalization and health utilization over time. Is that right? Is that right, Nick?
FDA Law
SEPTEMBER 20, 2021
Torrente, explained in a previous post , in-person meetings create important opportunities for building rapport, and lead to more robust dialogue and collegial relationships between the Agency and sponsors. Livornese and Josephine M. If FDA accepts the application, the sponsor can then submit their supplement in two parts.
Expert insights. Personalized for you.
59 
Let's personalize your content